← Leaderboards
Bruce A Molitoris
Indiana Univ-Purdue Univ At Indianapolis
$16,100,927
Attributed
$19,740,009
Total exposure
19
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.6M · FY2005–21$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$44,898,766 · 21
VA$0 · 1
By mechanism
P30$20,180,124 · 8
R01$6,936,138 · 4
P01$5,813,857 · 2
P50$5,283,057 · 2
R44$4,215,424 · 1
R42$1,836,148 · 2
Top collaborators
- Daniel Meier5 shared
- Simon J. Atkinson4 shared
- Kenneth W Dunn2 shared
- Thomas Joseph Carroll1 shared
- Ondine B Cleaver1 shared
- Denise K Marciano1 shared
- Leif Oxburgh1 shared
Most similar at Indiana Univ-Purdue Univ At Indianapolis
Same institution · by research overlap
- Malaz Boustani$18,696,098
- Kenneth W Dunn$10,198,541
Others in their field
Top investigators on “Kidney”
- Jeffrey P Krischer · University Of South Florida$540,222,210
- John M Lachin · George Washington University$155,894,464
- David M Nathan · Massachusetts Institute Of Technology$127,229,266
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$111,521,899
- David Heimbrook · Leidos Biomedical Research, Inc.$83,221,586
- Peter Scott Heeger · Case Western Reserve University$80,562,246
Research focus
KidneyTechnologyPhysiologyImageIndianaMicroscopicUniversitiesMicroscopyCellsResearch PersonnelRattusServicesAnimalsBaseFundingKidney DiseasesTwo-PhotonUrologicIn VivoOperative Surgical ProceduresFunctional DisorderDesignProgramsMolecular
Grant awards (113)
Proximal Tubule Albumin Transport in Disease States.$436,531
R01 · FY2021 · DK · contact PI
Intravital Imaging$240,811
P30 · FY2021 · DK · contact PI
Pilot and Feasibility Program$162,371
P30 · FY2021 · DK · contact PI
Administrative Core$56,432
P30 · FY2021 · DK · contact PI
Application of Progenitor Niche Signals to Ex Vivo Nephrogenesis$530,278
R56 · FY2020 · DK
Proximal Tubule Albumin Transport in Disease States.$435,922
R01 · FY2020 · DK · contact PI
Intravital Imaging$241,457
P30 · FY2020 · DK · contact PI
Pilot and Feasibility Program$162,372
P30 · FY2020 · DK · contact PI
Administrative Core$56,432
P30 · FY2020 · DK · contact PI
Center for Advanced Renal Microscopic Analysis$1,167,825
P30 · FY2019 · DK · contact PI
Proximal Tubule Albumin Transport in Disease States.$478,317
R01 · FY2019 · DK · contact PI
Intravital Imaging$241,457
P30 · FY2019 · DK · contact PI
Pilot and Feasibility Program$162,372
P30 · FY2019 · DK · contact PI
Administrative Core$56,432
P30 · FY2019 · DK · contact PI
Center for Advanced Renal Microscopic Analysis$32,000
P30 · FY2019 · DK · contact PI
Center for Advanced Renal Microscopic Analysis$1,167,825
P30 · FY2018 · DK · contact PI
Proximal Tubule Albumin Transport in Disease States.$484,125
R01 · FY2018 · DK · contact PI
Intravital Imaging$241,457
P30 · FY2018 · DK · contact PI
Pilot and Feasibility Program$162,372
P30 · FY2018 · DK · contact PI
Administrative Core$56,432
P30 · FY2018 · DK · contact PI
Center for Advanced Renal Microscopic Analysis$50,000
P30 · FY2018 · DK · contact PI
Administrative Core$50,000
P30 · FY2018 · DK · contact PI
Center for Advanced Renal Microscopic Analysis$1,182,200
P30 · FY2017 · DK · contact PI
Clinical and Non-Clinical Evaluations of repeat administrations of the FAST PV and mGFR Technology$997,989
R44 · FY2017 · DK
Proximal Tubule Albumin Transport in Disease States.$487,447
R01 · FY2017 · DK · contact PI
Intravital Imaging$241,457
P30 · FY2017 · DK · contact PI
Pilot and Feasibility Program$162,372
P30 · FY2017 · DK · contact PI
Administrative Core$56,432
P30 · FY2017 · DK · contact PI
Reducing Nephrotoxicity while enabling read through of missense stop codons by Gentamicin congeners$0
I01 · FY2017 · VA · contact PI
Center for Advanced Renal Microscopic Analysis$1,146,019
P30 · FY2016 · DK · contact PI
Clinical and Non-Clinical Evaluations of repeat administrations of the FAST PV and mGFR Technology$999,405
R44 · FY2016 · DK
INTRAVITAL MULTI-PHOTON MICROSCOPY CORE$274,590
P30 · FY2016 · DK · contact PI
Pilot and Feasibility Program$165,875
P30 · FY2016 · DK · contact PI
Enrichment Program$99,441
P30 · FY2016 · DK · contact PI
Administrative Core$73,644
P30 · FY2016 · DK · contact PI
Center for Advanced Renal Microscopic Analysis$28,899
P30 · FY2016 · DK · contact PI
Center for Advanced Renal Microscopic Analysis$1,146,019
P30 · FY2015 · DK · contact PI
Clinical and Non-Clinical Evaluations of repeat administrations of the FAST PV and mGFR Technology$999,701
R44 · FY2015 · DK
Proximal Tubule Albumin Transport in Disease States$407,160
R01 · FY2015 · DK · contact PI
INTRAVITAL MULTI-PHOTON MICROSCOPY CORE$274,590
P30 · FY2015 · DK · contact PI
Pilot and Feasibility Program$165,875
P30 · FY2015 · DK · contact PI
Enrichment Program$99,441
P30 · FY2015 · DK · contact PI
Administrative Core$73,644
P30 · FY2015 · DK · contact PI
Center for Advanced Renal Microscopic Analysis$50,418
P30 · FY2015 · DK · contact PI
Mechanisms and Key Molecular Target of Gentamacin Toxicity$0
I01 · FY2015 · VA · contact PI
Center for Advanced Renal Microscopic Analysis$1,146,019
P30 · FY2014 · DK · contact PI
Clinical Trial of the FAST Real-Time GFR System$1,045,698
R44 · FY2014 · DK
Proximal Tubule Albumin Transport in Disease States$407,160
R01 · FY2014 · DK · contact PI
Utilizing siRNA to Minimize Nephrotoxic Injury$334,950
R01 · FY2014 · DK
INTRAVITAL MULTI-PHOTON MICROSCOPY CORE$274,590
P30 · FY2014 · DK · contact PI
Pilot and Feasibility Program$165,875
P30 · FY2014 · DK · contact PI
Enrichment Program$99,441
P30 · FY2014 · DK · contact PI
Administrative Core$73,644
P30 · FY2014 · DK · contact PI
Center for Advanced Renal Microscopic Analysis$36,267
P30 · FY2014 · DK · contact PI
Mechanisms and Key Molecular Target of Gentamacin Toxicity$0
I01 · FY2014 · VA · contact PI
Center for Advanced Renal Microscopic Analysis$1,146,019
P30 · FY2013 · DK · contact PI
Proximal Tubule Albumin Transport in Disease States$392,910
R01 · FY2013 · DK · contact PI
Utilizing siRNA to Minimize Nephrotoxic Injury$323,228
R01 · FY2013 · DK
INTRAVITAL MULTI-PHOTON MICROSCOPY CORE$274,590
P30 · FY2013 · DK · contact PI
Pilot and Feasibility Program$165,875
P30 · FY2013 · DK · contact PI
Enrichment Program$99,441
P30 · FY2013 · DK · contact PI
Administrative Core$73,644
P30 · FY2013 · DK · contact PI
Center for Advanced Renal Microscopic Analysis$39,000
P30 · FY2013 · DK · contact PI
Mechanisms and Key Molecular Target of Gentamacin Toxicity$0
I01 · FY2013 · VA · contact PI
Center for Advanced Renal Microscopic Analysis$1,174,019
P30 · FY2012 · DK · contact PI
Proximal Tubule Albumin Transport in Disease States$407,160
R01 · FY2012 · DK · contact PI
Utilizing siRNA to Minimize Nephrotoxic Injury$334,950
R01 · FY2012 · DK
INTRAVITAL MULTI-PHOTON MICROSCOPY CORE$274,590
P30 · FY2012 · DK · contact PI
Pilot and Feasibility Program$165,875
P30 · FY2012 · DK · contact PI
Enrichment Program$99,441
P30 · FY2012 · DK · contact PI
Administrative Core$73,644
P30 · FY2012 · DK · contact PI
Proximal Tubule Albumin Transport in Disease States$67,461
R01 · FY2012 · DK · contact PI
Mechanisms and Key Molecular Target of Gentamacin Toxicity$0
I01 · FY2012 · VA · contact PI
Center for Advanced Renal Microscopic Analysis$955,208
P30 · FY2011 · DK · contact PI
Kidney Multiphoton Analysis of Therapeutic Agents$418,705
R42 · FY2011 · DK
Utilizing siRNA to Minimize Nephrotoxic Injury$385,000
R01 · FY2011 · DK
Proximal Tubule Albumin Transport in Disease States$337,306
R01 · FY2011 · DK · contact PI
Clinical Trial of the FAST Real-Time GFR System$172,631
R44 · FY2011 · DK
Center for Advanced Renal Microscopic Analysis$956,333
P30 · FY2010 · DK · contact PI
Kidney Multiphoton Analysis of Therapeutic Agents$417,462
R42 · FY2010 · DK
Non-Invasive Optical Determination of GFR$410,740
R42 · FY2010 · DK · contact PI
Center for Advanced Renal Microscopic Analysis$74,883
P30 · FY2010 · DK · contact PI
Center for Advanced Renal Microscopic Analysis$46,200
P30 · FY2010 · DK · contact PI
Center for Advanced Renal Microscopic Analysis$956,518
P30 · FY2009 · DK · contact PI
Non-Invasive Optical Determination of GFR$589,241
R42 · FY2009 · DK · contact PI
Center for Advanced Renal Microscopic Analysis$302,473
P30 · FY2009 · DK · contact PI
Center for Advanced Renal Microscopic Analysis$965,072
P30 · FY2008 · DK · contact PI
Ischemia-induced Actin Cytoskeletal Alterations$251,710
R01 · FY2008 · DK · contact PI
Non-Invasive Optical Determination of GFR$103,740
R41 · FY2008 · DK · contact PI
Center for Advanced Renal Microscopic Analysis$992,500
P30 · FY2007 · DK · contact PI
Ischemia-induced Actin Cytoskeletal Alterations$257,924
R01 · FY2007 · DK · contact PI
Center for Advanced Renal Microscopic Analysis$1,036,472
P50 · FY2006 · DK · contact PI
Ischemia-induced Actin Cytoskeletal Alterations$267,706
R01 · FY2006 · DK · contact PI
Center for Advanced Renal Microscopic Analysis$1,029,813
P50 · FY2005 · DK
Ischemia-induced Actin Cytoskeletal Alterations$284,063
R01 · FY2005 · DK
ACTIN DYSREGULATION IN ISCHEMIA: MECHANISMS AND EFFECTS$108,898
P01 · FY2005 · DK
Center for Advanced Renal Microscopic Analysis$37,634
P50 · FY2005 · DK
ACTIN DYSREGULATION IN ISCHEMIA: MECHANISMS AND EFFECTS$1,043,767
P01 · FY2004 · DK
Center for Advanced Renal Microscopic Analysis$1,034,256
P50 · FY2004 · DK
ACTIN DYSREGULATION IN ISCHEMIA: MECHANISMS AND EFFECTS$75,750
P01 · FY2004 · DK
Center for Advanced Renal Microscopic Analysis$34,642
P50 · FY2004 · DK
Center for Advanced Renal Microscopic Analysis$1,033,698
P50 · FY2003 · DK
ACTIN DYSREGULATION IN ISCHEMIA: MECHANISMS AND EFFECTS$1,013,365
P01 · FY2003 · DK
Center for Advanced Renal Microscopic Analysis$34,536
P50 · FY2003 · DK
Center for Advanced Renal Microscopic Analysis$1,042,006
P50 · FY2002 · DK
ACTIN DYSREGULATION IN ISCHEMIA: MECHANISMS AND EFFECTS$983,850
P01 · FY2002 · DK
Mechanisms of actin polymerization during ischemia$233,291
P01 · FY2002 · DK
RAB5 AND PI-3-KINASE AND GENTAMICIN TOXICITY$155,108
R01 · FY2002 · DK
ENDOTHELIAL CELL INJURY: QUANTIFYING ITS ROLE IN ISCHEMIC ACUTE RENAL FAILURE$0
P50 · FY2002 · DK
ACTIN DYSREGULATION IN ISCHEMIA: MECHANISMS AND EFFECTS$955,190
P01 · FY2001 · DK
Mechanisms of actin polymerization during ischemia$233,291
P01 · FY2001 · DK
ACTIN DYSREGULATION IN ISCHEMIA: MECHANISMS AND EFFECTS$933,164
P01 · FY2000 · DK
Mechanisms of actin polymerization during ischemia$233,291
P01 · FY2000 · DK